Gut immune system affects diabetes risk; increases inflammatory response


A new study has identified the gut immune system as a new and effective in treating a chronic disease. The research study conducted by the Diabetes Research Group in the Toronoto Research Institute was published by the Cell Metabolism journal and used a mouse model and humans to investigate the immune impact of gut bacteria.

“These results are novel and important because we have identified the immune system that lives in the gut as a new player in the control of blood sugar. This opens up the entire field of bowel immunology to the study of obesity and its complications such as high blood sugar,” said Dan Winer.

Mice fed a high fat high calorie diet had large amounts of pro-inflammatory immune cells and less of the regulating cells which help end an immune response, than in normal mice. The researchers found this same result in 14 humans, seven of whom were obese. The high-fat diet induces inflammatory changes in the immune cells in the bowel, upsetting the immune balance, which in turn sets off a chemical cascade, damaging the bowel wall, allowing bacterial products to leak into the blood stream. This leakage is what contributes to resistance, when the cells can no longer respond to and use effectively to stabilize blood sugar.

“If we could block the pro-inflammatory immune cells at the very beginning of this process, we could treat the disease more effectively,” reasons Shawn Winer, who is a gastrointestinal pathology fellow in the Laboratory Medicine Program at University Health Network (UHN). “By refocusing on the bowel, we open up many more therapeutic options as we already have a number of approved drugs available to treat an inflamed bowel.”


Helen Luck, Sue Tsai, Jason Chung, Xavier Clemente-Casares, Magar Ghazarian, Xavier S. Revelo, Helena Lei, Cynthia T. Luk, Sally Yu Shi, Anuradha Surendra, Julia K. Copeland, Jennifer Ahn, David Prescott, Brittany A. Rasmussen, Melissa Hui Yen Chng, Edgar G. Engleman, Stephen E. Girardin, Tony K.T. Lam, Kenneth Croitoru, Shannon Dunn, Dana J. Philpott, David S. Guttman, Minna Woo, Shawn Winer, Daniel A. Winer. Regulation of Obesity-Related Resistance with Gut Anti-inflammatory Agents. Cell Metabolism, 2015; 21 (4): 527 DOI: 10.1016/j.cmet.2015.03.001

Be Sociable, Share!

    Leave a Reply

    Your email address will not be published. Required fields are marked *